IL6 and neoplasm: Currently, chemotherapy exposure markedly increases the release of inflammatory cytokines such as IL-6 and IL-8 in the tumor microenvironment, promoting cancer cell survival and self-renewal signaling of cancer stem cells, which are crucial for drug resistance and relapse [18,19].